Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancer

Clinical trial NCT00003583 · UNKNOWN

Trial details

NCT number: NCT00003583
Sponsor: University of Florida
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Drug/Agent Toxicity by Tissue/Organ Lung Cancer Radiation Toxicity

Start date: 1997-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.